Feinstein Institute Breakthrough in Alzheimer’s Research
A Novel Approach to Targeting Amyloid Beta
Researchers at the Feinstein Institutes for Medical Research have made a significant breakthrough in Alzheimer’s research, focusing on a novel approach to tackling amyloid beta plaques, a hallmark of the disease. Instead of directly targeting the plaques themselves, their innovative strategy concentrates on